|
|||||
|
|
Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder‐preservation therapy for muscle‐invasive bladder cancer |
|
| Authors: | David B. Cahn DO MBS Elizabeth A. Handorf PhD Eric M. Ghiraldi DO Benjamin T. Ristau MD MHA Daniel M. Geynisman MD Thomas M. Churilla MD Eric M. Horwitz MD Mark L. Sobczak MD David Y. T. Chen MD Rosalia Viterbo MD Richard E. Greenberg MD Alexander Kutikov MD Robert G. Uzzo MD Marc C. Smaldone MD MSHP |
| Affiliation: | 1. Department of Urology, Einstein Healthcare Network, Philadelphia, Pennsylvania;2. Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;3. Department of Bioinformatics and Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania;4. Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;5. Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania |
| Abstract: | |
| Keywords: | bladder‐preservation therapy chemoradiotherapy muscle‐invasive bladder cancer radical cystectomy survival analyses temporal trends |